IL103600A0 - Method and kit for cancer diagnosis - Google Patents

Method and kit for cancer diagnosis

Info

Publication number
IL103600A0
IL103600A0 IL103600A IL10360092A IL103600A0 IL 103600 A0 IL103600 A0 IL 103600A0 IL 103600 A IL103600 A IL 103600A IL 10360092 A IL10360092 A IL 10360092A IL 103600 A0 IL103600 A0 IL 103600A0
Authority
IL
Israel
Prior art keywords
kit
cancer diagnosis
diagnosis
cancer
Prior art date
Application number
IL103600A
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL103600A priority Critical patent/IL103600A0/en
Publication of IL103600A0 publication Critical patent/IL103600A0/en
Priority to PCT/US1993/010411 priority patent/WO1994010575A1/en
Priority to AU55434/94A priority patent/AU5543494A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
IL103600A 1992-10-30 1992-10-30 Method and kit for cancer diagnosis IL103600A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL103600A IL103600A0 (en) 1992-10-30 1992-10-30 Method and kit for cancer diagnosis
PCT/US1993/010411 WO1994010575A1 (en) 1992-10-30 1993-10-29 Method and kit for cancer diagnosis
AU55434/94A AU5543494A (en) 1992-10-30 1993-10-29 Method and kit for cancer diagnosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL103600A IL103600A0 (en) 1992-10-30 1992-10-30 Method and kit for cancer diagnosis

Publications (1)

Publication Number Publication Date
IL103600A0 true IL103600A0 (en) 1993-03-15

Family

ID=11064167

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103600A IL103600A0 (en) 1992-10-30 1992-10-30 Method and kit for cancer diagnosis

Country Status (3)

Country Link
AU (1) AU5543494A (en)
IL (1) IL103600A0 (en)
WO (1) WO1994010575A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444969C1 (en) * 1994-12-16 1996-10-24 Orga Med Dr Med Erwin Klopfer Detection of antibodies against p53 in body fluids
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US5952178A (en) 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6268136B1 (en) 1997-06-16 2001-07-31 Exact Science Corporation Methods for stool sample preparation
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
EP2325321A1 (en) * 1999-05-28 2011-05-25 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
CN1300580C (en) * 2004-12-31 2007-02-14 中国人民解放军第306医院 Mass spectrum model for detecting liver cancer serum characteristic protein and method for preparation
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples

Also Published As

Publication number Publication date
WO1994010575A1 (en) 1994-05-11
AU5543494A (en) 1994-05-24

Similar Documents

Publication Publication Date Title
GB9612528D0 (en) Method for diagnosing cancer
EP0825878A4 (en) Composition and method for tumor imaging
HU9400710D0 (en) 2-debenzoyl-2-acyl-taxol derivatives and methods for making same
AP9700939A0 (en) Compounds and methods for the treatment of cancer
EP0851759A4 (en) Compounds and methods
IL101409A0 (en) Method for the early diagnosis of cancer
IL103600A0 (en) Method and kit for cancer diagnosis
EP0734398A4 (en) Compounds and methods
ZA95701B (en) Rivets-nails and methods for their implementation
IL106037A0 (en) Therapeutic and diagnostic methods based on neurotrophin-4-expression
EP0561564A3 (en) Apparatus and methods for providing design advice
GB9204409D0 (en) Determination method
AU3177893A (en) Method for diagnosing and treating cancer
GB9316369D0 (en) Diagnostic method
EP0799225A4 (en) Compounds and methods
GB2270752B (en) Diagnostic method
GB9217116D0 (en) Methods
GB9201803D0 (en) Methods
GB9201804D0 (en) Methods
HUT75422A (en) Gypsbonded forms and method for making thereof
DE4495155T1 (en) Diagnosis method
EP0490839A3 (en) Method and kit for enzyme-immunoassay
GB9210170D0 (en) Diagnostic method
GB9222661D0 (en) Diagnostic method
GB9218197D0 (en) Diagnostic method